Ignite Creation Date:
2024-05-06 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 2:15 PM
Study NCT ID:
NCT05080868
Status:
COMPLETED
Last Update Posted:
2021-10-18
First Post:
2021-03-12
Brief Title:
Infantile Hemangioma With Minimal or Arrested Growth Epidemiology Clinical Characteristics and Evolution
Sponsor:
Central Hospital Nancy France
Organization:
Central Hospital Nancy France
Study Overview
Official Title:
Comparing Epidemiological and Clinical Characteristics of Infantile Hemangioma With Minimal or Arrested Growth IH-MAG and Classic Infantile Hemangioma a Retrospective Study
Status:
COMPLETED
Status Verified Date:
2021-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Infantile hemangioma IH is the most common vascular tumor of infancy characterized by its clinical history Absent at birth or present under the form of a premonitory mark they display a rapid proliferative phase starting in the first weeks of life Then after a plateau phase they slowly involute However a subtype of IH named abortive minimal or arrested growth reticular or telangiectatic hemangioma differs from typical IH because it doesnt have a proliferative component or only a minimal one This subtype of hemangioma has been recently described and data are lacking regarding its proportion among infantile hemangioma and its differences with classic infantile hemangioma The aim of this study is to estimate the proportion of abortive hemangioma among infantile hemangioma Also the investigators aim to compare the clinical characteristics of classic infantile hemangiomas and abortive hemangiomas Lastly investigators wished to study the evolution of abortive hemangioma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None